Skip to main content
Clinical Trials/NCT05429437
NCT05429437Enrolling By InvitationPhase 1

Assesment of Two Different Modalities of Maxillary Canine Retraction Assisted With Injectable Platelet Rich Fibrin: A Prospective Clinical Study

Al-Azhar University1 site in 1 country18 target enrollmentStarted: November 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Enrolling By Invitation
Enrollment
18
Locations
1
Primary Endpoint
assessment of acceleration of canine retraction

Study Overview

Brief Summary

The present prospective clinical study will be undertaken for assessment of two different modalities of maxillary canine retraction assisted with injectable platelet rich fibrin.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
15 Years to 22 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •An age range from 15-22 years.
  • •Severe crowding or protrusion requiring 1st premolars extractions followed by symmetrical canine retraction.
  • •All permanent teeth present, 3rd molars are excluded.
  • •Good oral and general health.
  • •No systemic disease/medication that could interfere with OTM. No previous orthodontic treatment.

Exclusion Criteria

  • •Patient diagnosed to have an indication for non-extraction approach.
  • •Poor oral hygiene or periodontally compromised patient.
  • •Patient with craniofacial anomalies or previous history of trauma, bruxism or parafunctions.

Arms & Interventions

Group I

Active Comparator

will include 9 patients

Intervention: Injectable platelet rich fibrin . (Biological)

Group II

Active Comparator

will include 9 patients.

Intervention: Injectable platelet rich fibrin . (Biological)

Outcomes

Primary Outcomes

assessment of acceleration of canine retraction

Time Frame: post interventional at 4 months

rate of canine retraction

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

mohamed radwan mohamed radwan el shamy

Principal investigator

Al-Azhar University

Study Sites (1)

Loading locations...

Similar Trials